Leffler Scott J. has filed 7 insider transactions across 2 companies since January 2024.
Most recent transaction: a tax payment of 6217 shares of MYRIAD GENETICS INC ($MYGN) on March 14, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 14, 2025 | MYRIAD GENETICS INC | $MYGN | Leffler Scott J. | Chief Financial Officer | F | Common Stock | 6217 | $10.07 | 218,393.0000 | 91,309,064 | 2.77% | 0.01% |
| March 13, 2025 | MYRIAD GENETICS INC | $MYGN | Leffler Scott J. | Chief Financial Officer | A | Common Stock | 72165 | $0.00 | 224,610.0000 | 91,309,064 | 47.34% | 0.08% |
| Jan. 29, 2025 | MYRIAD GENETICS INC | $MYGN | Leffler Scott J. | Chief Financial Officer | F | Common Stock | 12230 | $12.54 | 152,445.0000 | 0 | 7.43% | 0.00% |
| March 14, 2024 | MYRIAD GENETICS INC | $MYGN | Leffler Scott J. | Chief Financial Officer | A | Common Stock | 46905 | $0.00 | 164,675.0000 | 0 | 39.83% | 0.00% |
| March 14, 2024 | MYRIAD GENETICS INC | $MYGN | Leffler Scott J. | Chief Financial Officer | A | Common Stock | 46095 | $0.00 | 163,865.0000 | 0 | 39.14% | 0.00% |
| Jan. 25, 2024 | CLOVER HEALTH INVESTMENTS, CORP. /DE | $CLOV | Leffler Scott J. | Chief Financial Officer | F | Class A Common Stock | 83538 | $0.98 | 4,857,303.0000 | 482,176,127 | 1.69% | 0.02% |
| Jan. 29, 2024 | MYRIAD GENETICS INC | $MYGN | Leffler Scott J. | Chief Financial Officer | A | Common Stock | 117770 | $0.00 | 117,770.0000 | 0 | 9999.99% | 0.00% |